Langerhans cells (LCs) are bone marrow-derived immature skin-residential dendritic cells (DCs) with a life cycle distinct from that of other types of DCs. The mechanisms involved in LC homeostasis and immunological functions are still not clear. MicroRNAs (miRNAs) are a class of short noncoding RNAs that regulate gene expression through either translational repression or mRNA degradation. A recent study showed that specific deletion of total miRNAs in DCs affects the homeostasis and function of only LCs, but not of other types of DCs. The roles of specific individual miRNA in LC development are still lacking. The miRNA miR-17-92 class, encoding miR-17, miR-18, miR-19a, miR-19b, miR-20 and miR-92, plays a very important role in B-and T-cell development and function. Here, we first report that epidermal LCs highly express the miR-17-92 class compared with spleen naive T cells. To further characterize the role of miR-17-92 in LC development, we generated LC-specific miR-17-92 knockout and knock-in mice. Interestingly, LC-specific gain-and loss-of-function of miR-17-92 cluster did not significantly change LC homeostasis, maturation ability, antigen capture and migration to draining lymph nodes. Thus, the miR-17-92 cluster may be functionally redundant and not critically required for LC development and function.
INTRODUCTION
MicroRNAs (miRNAs) are a class of short (B22 nt) noncoding RNAs that regulate gene expression through either translational repression or mRNA degradation. 1 Accumulated studies have shown that miRNAs are key regulators in immune cell development, [1] [2] [3] [4] and have been implicated in skin cancer and inflammatory diseases, including melanoma, psoriasis and atopic dermatitis. Using a mouse model with the deletion of Dicer, a ribonuclease III enzyme required for the processing of mature and functional miRNAs, studies from our group and of others indicated that a lack of miRNAs by deletion of Dicer dramatically interrupts T-and B-cell development and function. [1] [2] [3] Langerhans cells (LCs) are bone marrow-derived immature skin-residential dendritic cells (DCs) with a life cycle distinct from that of other types of DCs. 5, 6 LCs have the ability to traffic peripherally acquired antigens to skin-draining lymph nodes (LNs) and present antigens to T cells and then initiate adaptive immune responses or induce tolerance. LCs have been linked to the regulation of development of various skin diseases, including cancer, autoimmune diseases and allergy contact dermatitis. Although considerable progress has been made recently in identifying the developmental requirements of LCs, including TGFb1, inhibitor of DNA binding protein 2, runt-related transcription factor 3, the receptor for macrophage colony-stimulating factor, receptor activation of NF-KB ligand and aryl hydrocarbon receptor (AhR), the mechanisms involved in LC homeostasis and immunological functions are still not clear. 5, 6 A recent study showed that the deletion of Dicer specifically in DCs affects the homeostasis and function of only LCs, but not of other types of DCs, suggesting the specific roles of miRNAs in LC development and function. 7 We have recently reported that miR-223 and miR-150 regulate LC-mediated T-cell proliferation. 8, 9 However, the roles of specific individual miRNA in LC development are still lacking.
The miRNA miR-17-92 cluster is one of the polycistronic miRNA clusters and contains six individual miRNAs. These miRNAs are categorized into three families based on sequence homology: the miR-17 family (miR-17, miR-20 and miR-18a), the miR-19 family (miR-19a and miR-19b) and miR-92a. Given its high expression in certain tumors and its potent acceleration on c-Myc-induced lymphoma, the miR-17-92 cluster is well recognized as an onco-miR. Mice with germline deletion of miR-17-92 exhibit a severe defect in B-cell development with an augmentation of apoptosis in the pro-B-cell fraction and consequently a blockade at the pro-B to pre-B transition. In addition, transgenic mice overexpressing the miR-17-92 cluster in lymphocytes develop lymphoproliferative disease and autoimmunity at as early as 18 weeks of age. 10 Recent studies also suggested that miR-17-92 can promote Th1 cell responses, prevent inducible Treg differentiation and regulate CD8 memory T cells. However, the physiologic roles of endogenous miR-17-92 in DC development and function remain elusive.
RESULTS AND DISCUSSION
Using a TaqMan RT-PCR approach, we identified that the miR-17-92 cluster was highly expressed in freshly isolated skin LCs ( Figure 1a ) and bone marrow-derived DCs (data not shown) compared with that in naive splenic T cells. Interestingly, by computational biologic analyses (TargetScan 5.1; http://www. targetscan.org/worm_12/docs/help.html), we found that the miR-17-92 cluster potentially targets receptor activation of NF-KB ligand, runt-related transcription factor 3 and aryl hydrocarbon receptor genes that are reported to be involved in skin LC development, 5 which raised the possibilities that the miR-17-92 cluster may regulate LC development. To test this hypothesis, we took LC-specific gain-and loss-of-function approaches to analyze the physiologic roles of the miR-17-92 cluster in LCs.
By crossing human LC-cre mice with miR-17-92loxp mice, we first generated LC-specific miR-17-92 knockout mice (downregulated miRNAs (41 fold, log2) were confirmed by TaqMan RT-PCR (data not shown here)). As shown in Figure 1b , loss of miR-17-92 cluster did not affect the langerin þ LC ratio in skin. When immature LCs are matured in vitro, they highly express co-stimulatory molecules necessary for stimulation of T cells, including CD80 and CD86. To test the role of miR-17-92 in LC maturation, the frequencies and expression levels of LC maturation markers were evaluated after in vitro culture. As shown in Figure 1c , the percentages of CD86-and CD80-positive LCs were comparable between miR-17-92KO and WT mice, and their expression levels based on mean fluorescence intensity were also unchanged (data not shown). To evaluate the role of miR-17-92 in the antigen-uptake function of LCs, freshly isolated epidermal cells were incubated with FITC-dextran. As shown in Figure 1d , the phagocytic capacity of LCs from miR-17-92KO mice was not significantly changed compared with control mice, based on the frequencies of FITC þ LCs and their mean fluorescence intensity expression (data not shown). To further assess the role of miR-17-92 in LC antigen capture and migration capability in vivo, FITC was applied onto the skin of miR-17-92KO mice as a tracer, and the frequency of FITC-positive LCs on gated Langerin þ Epicam þ cells was compared. No significant difference was identified between WT and miR-17-92KO mice (Figure 1e ). Thus, loss of miR-17-92 did not change LC homeostasis, maturation ability, antigen capture and migration to draining LNs.
Given that miRNAs negatively regulate their targets, overexpression of miR-17-92 should downregulate its potential targets, receptor activation of NF-KB ligand, runt-related transcription factor 3, or aryl hydrocarbon receptor genes, which may inhibit LC development. Thus, we next generated mice with LC-specific miR-17-92 overexpression by crossing hLC-Cre mice with ROSA-miR-17-92 knock-in mice (upregulated miRNAs (41 fold, log2) were confirmed by TaqMan RT-PCR (data not shown here)). As shown in Figure 2 , overexpression of miR-17-92 in LCs did not change the epidermal LC ratio (Figure 2a) , maturation in vitro (Figure 2b ) and antigen uptake (Figure 2c ). Previous studies indicated that LCs are involved in allergic contact dermatitis. We further investigated the potential role of miR-17-92 expressed in LCs on 2,4-dinitrofluorobenzene-induced allergic contact dermatitis using both miR-17-92KO and miR-17-92KI mouse models. Mice were sensitized by applying 0.5% dinitrofluorobenzene topically on shaved abdominal skin. On day 5, sensitized mice were challenged topically with 0.2% dinitrofluorobenzene. However, LC-specific gain-and loss-offunction of miR-17-92 did not significantly affect allergic contact dermatitis development. Furthermore, there were no significant changes between mutant-and WT-LCs-induced CD4 and CD8 T-cell proliferation (data not shown).
In conclusion, the miR-17-92 cluster is highly expressed in epidermal LCs. However, miR-17-92 is not critically required for LC homeostasis, maturation, antigen capture and migration to draining LNs, suggesting that miR-17-92 may play no role in LC development and functions examined or could be related to the functional redundancy with multiple miRNAs expressing in LCs. The underlying specific miRNAs and related molecular mechanisms that govern LC development remain to be further determined.
MATERIALS AND METHODS Mice
MiR-17-92loxp and miR-17-92KI mice were described previously 10, 11 and were crossed with human LC-Cre mice 12, 13 to generate skin Langerhans cell-specific knockout and knock-in mice. Experiments were conducted at 4 to 6 weeks of age, unless otherwise indicated. Mice were housed in a specific pathogen-free barrier unit. Handling of mice and experimental procedures were in accordance with requirements of the Institutional Animal Care and Use Committee.
Genotyping miR-17-92loxp mice were genotyped using the following PCR primer pairs: 5'-TCGAGTATCTGACAATGTGG-3' and 5'-TAGCCAGAAGTTCCAAATTGG-3'. The mutant allele produced a 289-bp PCR product; whereas the wildtype allele resulted in a 255-bp product. miR-17-92KI mice were genotyped using the following PCR primer pairs: for a mutant PRC product (267 bp), 5'-ACCTCCCCCTGAACCTGAAACA-3' and 5'-CAGTTTTACAAGGTGATGTTCT CTG-3'; for a wild-type product (604 bp), 5'-CCAAAGTCGCTCTGAGTTG TTATC-3' and 5'-GAGCGGGAGAAATGGATATG-3'. Human LC-cre typing was used in the following PCR primer pair: 5'-GAGGCAAATGATTGGCA TTCTAC-3' and 5'-CTGGAAAATTCAAGAAGAGCCT-3' to generate a 271-bp product.
Single-cell suspension preparations
Epidermal and dermal cell suspensions were prepared from the ears and trunk skin of miR-17-92KO, miR-17-92KI and littermate control mice as described. 14, 15 Briefly, skin was rinsed with 70% alcohol; ears were split with fine forceps and placed, dermal side down, in 0.5% dispase (Gibco, Life Technologies, Grand Island, NY, USA) in 1 Â PBS (without calcium or magnesium) for 60 min at 37 1C. In the case of trunk skin, the subcutaneous fat was scraped off before placing in dispase. Epidermal sheets were then peeled from the underlying dermis and floated in complete culture medium with 100 mg per ml DNase (Sigma, St Louis, MO, USA) in a shaking water bath for 20 min at 37 1C. The single epidermal cells were harvested after filtering the cell suspension through a 70 mM filter. Complete culture medium was RPMI 1640 (with 2 mM L-glutamine, Gibco) supplemented with 10% heat-inactivated FBS (Hyclone, Thermo Scientific, Pittsburgh, PA, USA), 5 Â 10 À 5 M 2-mercaptoethanol, 0.15% sodium hydrogencarbonate, 1 mM sodium pyruvate, nonessential amino acids, 100 U per ml penicillin and 100 mg per ml streptomycin (Gibco).
Flow cytometry and antibodies
Epidermal cell suspensions were pretreated with 2.4G2 for 10 min at 4 1C. Cells were then stained for extracellular markers and/or intracellular marker. The following conjugated monoclonal antibodies were used: I-A/E (M5/114.15.2), CD45.2, CD80 (16-10A1), CD86 (GL1), CD3e (145-2C11), CD4 (GK1.5), EpCAM (G8.8) and langerin (929F3.01). All antibodies were purchased from eBioscience (San Diego, CA, USA) or Dendritics (Lyon, France). Cells were analyzed with a BD LSR II flow cytometer using CELLQuest Pro software or FACSAria II (BD Biosciences, San Jose, CA, USA).
T cells and Langerhans cell sorting
Epidermal cells were first stained with PE-labeled anti-I-A/E (M5/114.15.2) followed by anti-PE-beads, and then LCs were enriched by AutoMACS (up to 30%). The CD45.2 and MCHII double-positive LCs were further sorted by a FACSAria II cell sorter. The purity of LCs was up to 96%.
Real-time RT-PCR
RNAs from sorted spleen T cells and fresh Langerhans cells from C57B6 mice were purified using the Qiagen miRNA isolation kit (Qiagen, Germantown, MD, USA) according to the manufacturer's instructions. The expression of miR-17-92 was examined using the Applied Biosystems TaqMan MicroRNA Assay kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions; snoRNA135 was used as endogenous control. PCR amplification was carried out on the Applied Biosystems 7900 Real-Time PCR system, and relative fold changes for miR-17-92 were calculated in fresh LCs versus spleen T cells.
Phagocytosis assay
Freshly separated epidermal cells were cultured with 0.25 mg per ml Dextran-Fluorescence (Life Technologies, Grand Island, NY, USA) for 45 min at 37 1C or 41C. Cells were then collected and washed with ice-cold 1 Â PBS containing 1% FBS. After staining with APC-labeled anti-CD45.2 and PE-labeled anti-I-A/E, the percentage of LCs that uptake antigen (CD45.2 þ /I-A/E/FITC þ ) was determined by flow cytometry.
In vitro maturation 
